Literature DB >> 27189016

The Degree of Anisocytosis Predicts Survival in Patients with Primary Myelofibrosis.

Marko Lucijanic1, Vlatko Pejsa, Ozren Jaksic, Zdravko Mitrovic, Cedna Tomasovic-Loncaric, Tajana Stoos-Veic, Zeljko Prka, Mario Pirsic, Visnja Haris, Tamara Vasilj, Rajko Kusec.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27189016     DOI: 10.1159/000445247

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  4 in total

1.  Higher red blood cell distribution width predicts thrombosis risk in primary and secondary myelofibrosis.

Authors:  Marko Lucijanic; Ivan Krecak; Srdan Verstovsek; Ena Soric; Davor Galusic; Hrvoje Holik; Vlatka Perisa; Martina Moric Peric; Ivan Zekanovic; Rajko Kusec
Journal:  Ann Hematol       Date:  2021-11-26       Impact factor: 3.673

Review 2.  Cardiovascular Disease in Myeloproliferative Neoplasms: JACC: CardioOncology State-of-the-Art Review.

Authors:  Orly Leiva; Gabriela Hobbs; Katya Ravid; Peter Libby
Journal:  JACC CardioOncol       Date:  2022-06-21

3.  Increased mean platelet volume (MPV) is an independent predictor of inferior survival in patients with primary and secondary myelofibrosis.

Authors:  Marko Lucijanic; Zdravko Mitrovic; David Cicic; Zeljko Prka; Vlatko Pejsa; Ana Livun; Tajana Stoos-Veic; Zeljko Romic; Marcela Zivkovic; Iva Lucijanic; Zrinka Fabris; Rajko Kusec
Journal:  Int J Hematol       Date:  2017-10-11       Impact factor: 2.490

4.  Red cell distribution width is a potent prognostic parameter for in-hospital and post-discharge mortality in hospitalized coronavirus disease 2019 patients: a registry-based cohort study on 3941 patients.

Authors:  Marko Lucijanić; Ana Jordan; Ivana Jurin; Nevenka Piskač Živković; Ena Sorić; Irzal Hadžibegović; Armin Atić; Josip Stojić; Diana Rudan; Ozren Jakšić; Nikolina Bušić; Lovorka Đerek; Ivica Lukšić; Bruno Baršić
Journal:  Croat Med J       Date:  2022-02-28       Impact factor: 1.351

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.